Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-01 Sale | 2022-07-06 5:00 pm | Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON Former 10% Owner | 500,000 | $2.888 | $1,444,012 | 3,824,883 (Indirect) | View |
| 2022-06-29 Sale | 2022-07-01 4:10 pm | Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON 10% Owner | 475,966 | $2.7695 | $1,318,201 | 4,324,883 (Indirect) | View |
| 2022-05-02 Sale | 2022-05-04 5:17 pm | Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON 10% Owner | 600 | $2.7 | $1,620 | 4,800,849 (Indirect) | View |
| 2022-04-28 Sale | 2022-05-02 5:04 pm | Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON 10% Owner | 23,434 | $2.7535 | $64,525 | 4,801,449 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:29 pm | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:26 pm | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:24 pm | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:21 pm | Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:18 pm | Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:13 pm | Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:10 pm | Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner | 3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:04 pm | Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner | 2,631,578 | $1.9 | $4,999,998 | 10,421,428 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 5:00 pm | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 2,631,578 | $1.9 | $4,999,998 | 10,421,428 (Direct) | View |
| 2021-10-18 Purchase | 2021-10-19 9:17 pm | Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner | 1,851,852 | $0 | $0 | 11,493,554 (Indirect) | View |
| 2021-10-18 Purchase | 2021-10-19 9:15 pm | Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner | 1,851,852 | $0 | $0 | 11,493,554 (Indirect) | View |
| 2021-10-18 Purchase | 2021-10-19 9:15 pm | Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner | 1,851,852 | $0 | $0 | 11,493,554 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-23(A) Option Award | 2022-07-01 4:59 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23(A) Option Award | 2022-07-01 4:58 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23(A) Option Award | 2022-07-01 4:56 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23(A) Option Award | 2022-07-01 4:54 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23(A) Option Award | 2022-07-01 4:52 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:51 pm | 2022-06-29 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:49 pm | 2022-06-29 2031-02-16 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:47 pm | 2022-06-29 2031-02-16 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L CEO | 128,000 | $0 | 128,000 (Direct) | View |
| 2022-02-11(A) Option Award | 2022-07-01 4:44 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-02-11(A) Option Award | 2022-07-01 4:43 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 137,500 | $0 | 137,500 (Direct) | View |
| 2022-02-14(A) Option Award | 2022-07-01 4:41 pm | N/A 2032-02-13 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L CEO | 275,000 | $0 | 275,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 5:04 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 5:01 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 4:59 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 4:47 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 4:41 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 4:38 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-04-11 Option Award | 2022-04-13 5:32 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 948,948 | $1.9 | 3,948,948 (Indirect) | View |
| 2022-04-11 Option Award | 2022-04-13 5:32 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 3,000,000 | $1.899 | 3,948,948 (Indirect) | View |
| 2022-02-11 Option Award | 2022-02-15 4:01 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa CFO | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 137,500 | $0 | 137,500 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-13 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L CEO | 275,000 | $0 | 275,000 (Direct) | View |
| 2022-01-12 Ownership | 2022-01-21 6:13 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | TPG GP A LLC WINKELRIED JON 10% Owner | 0 | $0 | 4,824,883 (Indirect) | View |